Home Approval of new antibiotic by Cubist to help in $100 trillion global fight
 

Keywords :   


Approval of new antibiotic by Cubist to help in $100 trillion global fight

2014-12-22 17:40:08| Biotech - Topix.net

Friday's FDA approval of the latest new antibiotic by Cubist Pharmaceuticals is a step toward combating a problem estimated to kill 10 million people and cost $100 trillion globally by 2050. Late Friday, U.S. regulators gave the nod to Zerbaxa, formerly known by the generic name of ceftolozane/tazobactam, for the treatment of adults with complicated urinary tract infections and complicated intra-abdominal infections caused by certain so-called Gram-negative bacteria, typically considered among the hardest to kill.

Tags: global fight approval antibiotic

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
14.1115kg 50mm
14.11ONE PIECE BOX
14.11DAIWA OCEAN STAR 500
14.11fender jhon mayer blackone
14.11 Angel Touch Plus vol.3
14.11Strymon BigSky
14.11
14.11 TOUR B X 2
More »